A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts
Jad El‐Hoss(UNSW Sydney), Richard B. Lock(Cancer Institute of New South Wales)
Cited by 29
Related Papers
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
|Clinical Cancer Research|2019|53
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression
|British Journal of Cancer|2018|44